Grant: Doctoral Award - Doctoral Foreign Study Award (DFSA)
Direct Payment
$105,000.00
Investigation of factors that enable National Essential Medicines Lists to improve or hinder access to essential cardiovascular disease medicines: case studies in Kenya and Uganda
FY 2017-18
Summary
The human right to health is challenged for many people worldwide due to a lack of access to essential medicines. The factors that support or impede the effective implementation of National Essential Medicines Lists (NEMLs), as a policy tool to ensure accessibility and affordability of essential medicines are currently poorly understood, particularly in low and middle-income countries. Disparities in access to medicines for cardiovascular disease (CVD), the number one cause of death worldwide, are a major human rights and equity concern as the poorest populations in low- and middle-income countries (LMICs) bear the highest burden of disability and death from CVD, and at younger ages.
Therefore, this study seeks to investigate the social, political and economic factors that enable or impede the successful implementation of National Essential Medicine Lists to improve availability and affordability of essential CVD medications in both the public and private health sectors in LMICs. A health policy analysis will be conducted focused on national level policy implementation processes in Kenya and Uganda. This cross-country
comparative study between Kenya and Uganda will make it possible to distinguish social, political or economic contextual factors influencing the successful implementation of NEMLs. The aim of this study is to
supply evidence to governments, United Nations Agencies, and civil society organizations that will deepen our understanding of factors that enable or hinder successful implementation of National Essential Medicine Lists. This evidence will be of great use to various actors on the path toward improving access to affordable CVD medicines and reducing preventable morbidity and mortality from CVD, in LMICs as well as developed nations such as Canada. The evidence will also be useful for understanding how to expand access to essential medicines in other disease areas.
Department
Program
Doctoral Award - Doctoral Foreign Study Award (DFSA)
Recipient
Location
United Kingdom
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
383272
Name
Jarvis Jordan D
Country
United Kingdom
Orgtype
Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Doctoral Research Awards - B
Projecttitle
Investigation of factors that enable National Essential Medicines Lists to improve or hinder access to essential cardiovascular disease medicines: case studies in Kenya and Uganda
Programtype2
Studentship Programs
Orgnameinp2
Direct Payment
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Doctoral Foreign Study Award (DFSA)
Keyworddelim
Cardiovascular Disease; Country Comparison; East Africa; Essential Medicines Policy; Health Policy Analysis; Kenya; National Essential Medicines List; Noncommunicable Diseases; Public Policy Frameworks; Uganda
Abstract
The human right to health is challenged for many people worldwide due to a lack of access to essential medicines. The factors that support or impede the effective implementation of National Essential Medicines Lists (NEMLs), as a policy tool to ensure accessibility and affordability of essential medicines are currently poorly understood, particularly in low and middle-income countries. Disparities in access to medicines for cardiovascular disease (CVD), the number one cause of death worldwide, are a major human rights and equity concern as the poorest populations in low- and middle-income countries (LMICs) bear the highest burden of disability and death from CVD, and at younger ages.
Therefore, this study seeks to investigate the social, political and economic factors that enable or impede the successful implementation of National Essential Medicine Lists to improve availability and affordability of essential CVD medications in both the public and private health sectors in LMICs. A health policy analysis will be conducted focused on national level policy implementation processes in Kenya and Uganda. This cross-country
comparative study between Kenya and Uganda will make it possible to distinguish social, political or economic contextual factors influencing the successful implementation of NEMLs. The aim of this study is to
supply evidence to governments, United Nations Agencies, and civil society organizations that will deepen our understanding of factors that enable or hinder successful implementation of National Essential Medicine Lists. This evidence will be of great use to various actors on the path toward improving access to affordable CVD medicines and reducing preventable morbidity and mortality from CVD, in LMICs as well as developed nations such as Canada. The evidence will also be useful for understanding how to expand access to essential medicines in other disease areas.
Competitiondate
201710
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Jarvis, Jordan D
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~